ELAB

PMGC Holdings Inc. ELAB

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode ELAB NKGN WINT NCEL MLEC DRMA BCTXZ PBM VRAX XRTX
6M -68.65 % -80.00 % -92.98 % -89.21 % -95.18 % 216.66 % -61.76 % -78.99 % -50.91 % -31.26 %
YTD -96.28 % -92.76 % -99.76 % -88.07 % -96.03 % 53.96 % -70.23 % -93.13 % -82.36 % -48.72 %
1Y -96.47 % -92.22 % -99.75 % -86.87 % -95.94 % 73.98 % -70.23 % -94.00 % -79.70 % -46.43 %
3Y -99.99 % -99.12 % -100.00 % -99.48 % -96.55 % -94.99 % -70.23 % -99.97 % -93.22 % -90.87 %
5Y -99.99 % -99.12 % -100.00 % -99.78 % -96.68 % -99.83 % -70.23 % -99.97 % -99.79 % -97.88 %
10Y -99.99 % -99.12 % -100.00 % -99.78 % -96.68 % -99.83 % -70.23 % -99.97 % -99.79 % -97.88 %
From the beginning -99.99 % -99.12 % -100.00 % -99.78 % -96.68 % -99.83 % -70.23 % -99.97 % -99.79 % -97.88 %

Dividend

XORTX Therapeutics Inc.